AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 65 filers reported holding AMRYT PHARMA PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $91,534,479 | +98.0% | 6,278,085 | -0.9% | 30.70% | +57.8% |
| Q4 2022 | $46,232,645 | +7.3% | 6,333,239 | +1.7% | 19.45% | +0.4% |
| Q3 2022 | $43,096,000 | -2.1% | 6,227,733 | -1.1% | 19.37% | -5.4% |
| Q2 2022 | $44,025,000 | -16.0% | 6,298,348 | -0.6% | 20.48% | -5.8% |
| Q1 2022 | $52,417,000 | -20.0% | 6,338,200 | +4.4% | 21.74% | -27.7% |
| Q4 2021 | $65,554,000 | -6.2% | 6,069,775 | +4.6% | 30.08% | -5.4% |
| Q3 2021 | $69,882,000 | +105.9% | 5,801,748 | +107.4% | 31.80% | +79.2% |
| Q2 2021 | $33,937,000 | -3.5% | 2,797,744 | +10.9% | 17.75% | -6.6% |
| Q1 2021 | $35,156,000 | +75.3% | 2,523,728 | +78.2% | 18.99% | +23.7% |
| Q4 2020 | $20,057,000 | +112.1% | 1,416,483 | +85.1% | 15.36% | +56.1% |
| Q3 2020 | $9,458,000 | – | 765,236 | – | 9.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 8,857,268 | $64,658,056 | 27.18% |
| Stonepine Capital Management, LLC | 6,333,239 | $46,232,645 | 19.45% |
| MPM ASSET MANAGEMENT LLC | 2,668,843 | $19,482,554 | 8.15% |
| Aquilo Capital Management, LLC | 2,098,993 | $15,322,649 | 5.76% |
| New Leaf Venture Partners, L.L.C. | 449,737 | $3,283,080 | 2.38% |
| Global Frontier Investments LLC | 505,000 | $3,687 | 1.62% |
| Telemetry Investments, L.L.C. | 130,262 | $951 | 1.50% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,333,552 | $46,235 | 1.27% |
| Rubric Capital Management LP | 3,600,000 | $26,280,000 | 1.15% |
| Clearline Capital LP | 631,942 | $4,613,176 | 0.82% |